Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (SHE:300313)
China · Delayed Price · Currency is CNY 7.12
-0.03 (-0.42%)
At close: Feb 13, 2026
SHE:300313 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 84.71 | 132.52 | 133.43 | 72.08 | 105.38 | 160.53 |
Other Revenue | 5.08 | 5.08 | 4.07 | 4.27 | 2.6 | 2.78 |
| 89.79 | 137.6 | 137.5 | 76.35 | 107.98 | 163.31 | |
Revenue Growth (YoY) | -39.42% | 0.07% | 80.09% | -29.29% | -33.88% | -28.69% |
Cost of Revenue | 93.8 | 155.7 | 122.12 | 67.06 | 105.06 | 136.95 |
Gross Profit | -4.01 | -18.1 | 15.38 | 9.29 | 2.92 | 26.36 |
Selling, General & Admin | 24.7 | 26.96 | 26.18 | 18.6 | 24.74 | 29.54 |
Research & Development | 1.13 | 1.16 | 1.51 | 0.51 | 1.5 | 0.76 |
Other Operating Expenses | 1 | 0.11 | 0.05 | 0.08 | 0.58 | 0.74 |
Operating Expenses | 27.1 | 28.85 | 28.73 | 18.25 | 29.05 | 31.42 |
Operating Income | -31.11 | -46.95 | -13.35 | -8.96 | -26.13 | -5.06 |
Interest Expense | -10.11 | -10.74 | -10.98 | -14.1 | -14.53 | -12.61 |
Interest & Investment Income | 3.08 | 3.47 | 3.24 | 0.25 | 1.37 | 8.19 |
Currency Exchange Gain (Loss) | - | - | 0 | 0.11 | -0.03 | 0.02 |
Other Non Operating Income (Expenses) | 2.16 | -0.12 | -0.7 | 0.26 | -2.34 | -1.07 |
EBT Excluding Unusual Items | -35.97 | -54.33 | -21.79 | -22.45 | -41.65 | -10.53 |
Gain (Loss) on Sale of Investments | - | - | - | -8.05 | - | - |
Gain (Loss) on Sale of Assets | -0.62 | -0.18 | -1.21 | -0.05 | 42.7 | 1.61 |
Asset Writedown | -1.93 | -10.64 | -0 | -0.82 | -33.48 | -3.17 |
Legal Settlements | -1.54 | -1.54 | -1.92 | -1.7 | - | - |
Other Unusual Items | 6.67 | 3.29 | 5.61 | 2.6 | 3.89 | 15.4 |
Pretax Income | -33.4 | -63.4 | -19.31 | -30.47 | -28.55 | 3.31 |
Income Tax Expense | 3.71 | 3.68 | 2.78 | 1.56 | 1.85 | 0.8 |
Earnings From Continuing Operations | -37.11 | -67.08 | -22.08 | -32.03 | -30.39 | 2.51 |
Minority Interest in Earnings | 1.1 | 1.13 | 0.08 | 0.2 | 3.09 | 1.7 |
Net Income | -36.02 | -65.95 | -22 | -31.83 | -27.3 | 4.21 |
Net Income to Common | -36.02 | -65.95 | -22 | -31.83 | -27.3 | 4.21 |
Shares Outstanding (Basic) | 313 | 313 | 314 | 318 | 303 | 313 |
Shares Outstanding (Diluted) | 313 | 313 | 314 | 318 | 303 | 313 |
Shares Change (YoY) | -0.55% | -0.42% | -1.26% | 4.93% | -3.07% | -2.18% |
EPS (Basic) | -0.12 | -0.21 | -0.07 | -0.10 | -0.09 | 0.01 |
EPS (Diluted) | -0.12 | -0.21 | -0.07 | -0.10 | -0.09 | 0.01 |
Free Cash Flow | -44.29 | 11.67 | -15.39 | -9.22 | -37.15 | 0.12 |
Free Cash Flow Per Share | -0.14 | 0.04 | -0.05 | -0.03 | -0.12 | - |
Gross Margin | -4.46% | -13.15% | 11.19% | 12.17% | 2.70% | 16.14% |
Operating Margin | -34.64% | -34.12% | -9.71% | -11.73% | -24.20% | -3.10% |
Profit Margin | -40.11% | -47.93% | -16.00% | -41.69% | -25.29% | 2.58% |
Free Cash Flow Margin | -49.32% | 8.48% | -11.20% | -12.07% | -34.40% | 0.07% |
EBITDA | -24.64 | -37.68 | -0.34 | 4.33 | -12.2 | 12.29 |
EBITDA Margin | -27.45% | -27.38% | -0.24% | 5.67% | -11.29% | 7.53% |
D&A For EBITDA | 6.46 | 9.27 | 13.01 | 13.29 | 13.93 | 17.36 |
EBIT | -31.11 | -46.95 | -13.35 | -8.96 | -26.13 | -5.06 |
EBIT Margin | -34.64% | -34.12% | -9.71% | -11.73% | -24.20% | -3.10% |
Effective Tax Rate | - | - | - | - | - | 24.14% |
Revenue as Reported | 89.79 | 137.6 | 137.5 | 76.35 | 107.98 | 163.31 |
Advertising Expenses | - | 1.27 | 0.29 | 0.04 | 0.03 | 0 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.